Live Breaking News & Updates on Balazs Halmos

Stay updated with breaking news from Balazs halmos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EGFR TKI–Based Combinations May Revolutionize Frontline EGFR+ NSCLC Management

Balazs Halmos, MD, discusses the FLAURA2 and MARIPOSA trials of EGFR TKIs plus chemotherapy in EGFR-mutated non–small cell lung cancer. ....

United States , New York , South Korea , Montefiore Einstein Comprehensive Cancer Center , Department Of Medicine Oncology Hematology , Department Of Oncology Medical , Annual Winter Lung Cancer , Medical Oncology , Clinical Science , First Line , Annual Winter Lung Cancer Conference , Natl Cancer , Patients With Egfr Mutated Advanced Non Small Cell Lung Cancer , Egfr Tkis , Winter Lung , Balazs Halmos ,

Dr Halmos on Treatment Strategies For EGFR-Mutant NSCLC

Balazs Halmos, MD, discusses treatment strategies for patients with EGFR-mutant non–small cell lung cancer. ....

Balazs Halmos , Montefiore Einstein Comprehensive Cancer Center , Department Of Oncology Medical , Department Of Medicine Oncology Hematology , Medical Oncology , Clinical Science , Patients With Egfr Mutant Non Small Cell Lung Cancer ,

Halmos Highlights Evaluation of the EGFR Inhibitor BDTX-1535 in NSCLC

Dr Halmos discusses the ongoing investigation of the potent, selective, and irreversible EGFR inhibitor BDTX-1535 in patients with non–small cell lung cancer. ....

New York , United States , Courtney Flaherty , Balazs Halmos , Live On Air , Black Diamond Therapeutics , Albert Einstein College , Montefiore Medical Center , Onclive On Air , Black Diamond , Apple Podcasts , Google Podcasts , Amazon Music , Bdtx 1535 , Patients With Non Small Cell Lung Cancer , Albert Einstein College Of Medicine Montefiore Medical Center ,

ESMO 2023: Experts Preview Anticipated Data Spanning Tumor Types

The 2023 ESMO Congress, which is taking place in Madrid, Spain, and will continue to be accessible online via a virtual platform, is gearing up to kick off, and the oncology community is ready to learn more about the latest data across malignancies. ....

United States , Ibiayi Dagogo Jack , Kishor Ganti , Novartis Pluvicto , Pembrolizumab Keytruda , Heather Mcarthur , Daiichi Sankyo , Balazs Halmos , Genentech Alecensa , Heather Wakelee , Jeffreys Weber , Dagogo Jack , Christopherk Glanz , Perlmutter Cancer Center , Bladder Cancer Research , Melanoma Research Program , Department Of Internal Medicine , Division Of Oncology Hematology , Harvard Medical School , Pamela Buffett Cancer Center , Drug Administration , Adventhealth Cancer Institute , Breast Cancer Program At Simmons Center , Department Of Oncology , Ut Southwestern Medical Center , Clinical Research Unit ,

Defining Earlier Use of Immunotherapy in Patients With NSCLC

In the non–small cell lung cancer space, identifying the appropriate candidate to receive perioperative approaches, such as neoadjuvant or adjuvant therapy, remains the clinical objective. ....

United States , New York , Bruna Pellini , Markg Kris , Leslyem Heisler , Charu Aggarwal , Balazs Halmos , H Lee Moffitt Cancer Center , Penn Center , Ny Montefiore Einstein Cancer Center , Airways Malignancies Research , Montefiore Einstein Cancer Center , Clinical Cancer Genomics , New York Lung Cancers Symposium , Targeted Therapies , Joy Ruane Chair , Thoracic Oncology , Memorial Sloan Kettering Cancer Center , Tumor Board , New England Journal , Lung Cancer , Associate Professor , Lung Cancer Excellence , Cancer Care Innovation , Penn Medicine , Morsani College ,